Literature DB >> 874742

Disposition of sulfonamides in food-producing animals IV: Pharmacokinetics of sulfamethazine in cattle following administration of an intravenous dose and three oral dosage forms.

R F Bevill, L W Dittert, D W Bourne.   

Abstract

The plasma and urine data obtained following intravenous administration of sulfamethazine to cattle were fit to a one-compartment pharmacokinetic model with a half-life of elimination of 9 hr and a volume of distribution of 0.35 liter/kg. Sulfamethazine was eliminated by excretion of unchanged sulfamethazine (18%) into urine and by formation of three metabolites subsequently excreted into urine. Sulfamethazine also was administered as a solution, a rapid-release bolus, and a sustained-release bolus. The change in the urinary metabolic pattern with different routes of administration suggested that first-pass metabolism was occurring during the absorption process. The absorption half-life was 6 hr. The absorption process for the two solid boluses kinetically appeared to include a dissolution step.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874742     DOI: 10.1002/jps.2600660503

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  The effect of food deprivation on the rate of sulfamethazine elimination in goats.

Authors:  A S Abdullah; J D Baggot
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

2.  Residual veterinary antibiotics in pig excreta after oral administration of sulfonamides.

Authors:  Jinrong Qiu; Tao Zhao; Qingyun Liu; Jinhua He; Dechun He; Genyi Wu; Yongtao Li; Chengai Jiang; Zhencheng Xu
Journal:  Environ Geochem Health       Date:  2015-07-12       Impact factor: 4.609

3.  Disposition of sulfadimethoxine in swine: inclusion of protein binding factors in a pharmacokinetic model.

Authors:  R F Bevill; G D Koritz; G Rudawsky; L W Dittert; C H Huang; M Hayashi; D W Bourne
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

4.  Nose to brain delivery of Efavirenz nanosuspension for effective neuro AIDS therapy: in-vitro, in-vivo and pharmacokinetic assessment.

Authors:  Smita Kakad; Sanjay Kshirsagar
Journal:  Heliyon       Date:  2021-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.